Pope Francis is making his first public appearance in five weeks before being discharged from the hospital where he was ...
At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...
Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...
The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...
Significant alterations in the structure and cellular composition of the distal lung are a defining characteristic of ...
A mere year into her career, Kara Leigh Roncin, MD, has already made a notable impact on the field of pathology ...
Prime Editing has potential to be best-in-class approach for AATD ---- Previously undisclosed program now emerging from within liver platform; ...
Pope registers new slight improvements in pneumonia fight as Vatican gives details on hospital photo
The 88-year-old pontiff is now able to spend some time during the day off high flows of oxygen and use just ordinary ...
Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...
The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.
A new study reveals differences in survival rates for COVID-19 pneumonia patients treated with ECMO compared to non-COVID-19 pneumonia patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results